The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-651

I'm not convinced that PAA can remove the ability for BPay to Operate..

This is to give SH a hurry up
1 Raise Capital from the SH Oppies first
2 calculate shortfall for Trial Costs
3 raise the residual funds required..

or
Deal in the wings and its Heads only getting paid similar to the RAP deal that Roger headlined with Pfizer last year..

Enjoy the weekend

Lack of Media Push on the Day lost momentum and now the consequence is rinsing through ..

How hard was it to orchestrate Media on the Day after the Phase I/II data was released after close??

There was ZERO Pre Open Media ... Opportunity Lost .... again if PAA aren't going to herald the positive data to investors then who is ?? The other 212 Biotechs also vying for Capital and pursuing new investors,,,,,

Great week for the Science absolutely brilliant , MPL couldn't have delivered any more than it did,,, Marketing on the day after results destroyed Momentum.
SP says it all ,,, and remember it was 4 years of Tablet development and trialing ,,, it should have been the biggest Media Release in the Company's History as it was the most important information ,, Pivotal ,,NZT